391. Evaluation of Second-Generation Triazoles in the Treatment of Refractory Coccidioidomycosis

por Yoon, Janet, Jolliff, Jeff, Andruszko, Brittany, Heidari, Arash, Johnson, Royce
Publicado 2018

Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma

por Rock, Adam, Uche, An, Yoon, Janet, Agulnik, Mark, Chow, Warren, Millis, Sherri
Publicado 2023

Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor

por Wei, Christina H., Wang, Edward, Sadimin, Evita, Rodriguez-Rodriguez, Lorna, Agulnik, Mark, Yoon, Janet, LoBello, Janine, Szelinger, Szabolcs, Anderson, Clarke
Publicado 2023

LGG-53. PNOC001 (NCT01734512): A PHASE II STUDY OF EVEROLIMUS FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMAS (pLGG)

por Mueller, Sabine, Aboian, Mariam, Nazemi, Kellie, Gauvain, Karen, Yoon, Janet, Minturn, Jane, Leary, Sarah, AbdelBaki, Mohamed S, Goldman, Stewart, Elster, Jennifer, Resnick, Adam, Molinaro, Annette M, Phillips, Joanna, Prados, Michael, Haas-Kogan, Daphne
Publicado 2020

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

por Heater, Natalie K., Okuno, Scott, Robinson, Steven, Attia, Steven, Seetharam, Mahesh, Siontis, Brittany L., Yoon, Janet, Chawla, Sant, Milhem, Mohammed M., Monga, Varun, Skubitz, Keith, Charlson, John, Hirbe, Angela C., Weiss, Mia C., Van Tine, Brian, Agulnik, Mark
Publicado 2023

HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS

por Robinson, Giles, Desai, Ami, Basu, Ellen, Foster, Jennifer, Gauvain, Karen, Sabnis, Amit, Shusterman, Suzanne, Macy, Margaret, Mease, Luke, Yoon, Janet, Cash, Thomas, Abdelbaki, Mohamed, Nazemi, Kellie, Pratilas, Christine, Weiss, Brian, Chohan, Saibah, Cardenas, Alison, Hutchinson, Katherine, Bergthold, Guillaume, Gajjar, Amar
Publicado 2020

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

por Desai, Ami V, Robinson, Giles W, Gauvain, Karen, Basu, Ellen M, Macy, Margaret E, Maese, Luke, Whipple, Nicholas S, Sabnis, Amit J, Foster, Jennifer H, Shusterman, Suzanne, Yoon, Janet, Weiss, Brian D, Abdelbaki, Mohamed S, Armstrong, Amy E, Cash, Thomas, Pratilas, Christine A, Corradini, Nadège, Marshall, Lynley V, Farid-Kapadia, Mufiza, Chohan, Saibah, Devlin, Clare, Meneses-Lorente, Georgina, Cardenas, Alison, Hutchinson, Katherine E, Bergthold, Guillaume, Caron, Hubert, Chow Maneval, Edna, Gajjar, Amar, Fox, Elizabeth
Publicado 2022